Structural Diversity of Dietary Carbohydrates Shapes Gut Microbiota, Digestive Physiology, Incretin Hormones, and Systemic Metabolic Health
This comprehensive review makes the case that carbohydrate structure is a key determinant of how dietary carbohydrates interact with the gut microbiome and drive metabolic outcomes. Drawing on mechanistic, experimental, and clinical evidence, the authors examine three major categories: digestible starches, soluble fibers, and insoluble fibers. The core argument is that structural features like chain length, branching patterns, the type of bonds connecting sugar units, and how tightly packed the starch granule is produced lead to fundamentally different microbial and physiological responses, even when total fiber intake appears identical.
The authors show that rapidly digestible starches produce quick glucose spikes and short-lived hormonal responses, while resistant and slowly digestible starches that reach the colon and get fermented support more stable blood sugar levels and healthier microbial diversity. That fermentation produces short-chain fatty acids, which signal the gut lining to release hormones like GLP-1, which slows digestion and blunts blood sugar spikes, and PYY, promoting fullness. Structurally complex fibers like arabinoxylan, beta-glucan, and pectin influence more diverse microbial communities because they require specialized enzymes to be broken down, showing that different fiber structures selectively feed different bacteria, shaping which metabolites get produced.
The review’s limitation is that most existing research lumps carbohydrates into broad categories, making it hard to draw precise conclusions about which structural features drive particular outcomes. Add in the fact that two people can consume the same type of fiber may experience meaningfully different results depending on their existing microbiome. The authors call for research that maps specific structural properties to specific microbial and metabolic responses. If completed, this could enable more precision nutrition strategies and the development of more intentionally designed functional ingredients.
Key Takeaways:
- Carbohydrate structure, not just fiber content, determines how dietary carbohydrates interact with gut bacteria and what metabolites they produce.
- Resistant and slowly digestible starches trigger the release of GLP-1 and PYY, hormones that regulate blood sugar and satiety, while rapidly digestible starches largely bypass this.
- Structurally complex fibers like arabinoxylan, beta-glucan, and pectin support broader microbial diversity by requiring specialized bacterial enzymes to break them down.
Access the study: https://doi.org/10.1007/s44417-026-00021-8
Reference: Kumar, P. P., Wang, Y., & Yao, T. (2026). Structural diversity of dietary carbohydrates shapes gut microbiota, digestive physiology, incretin hormones, and systemic metabolic health. Discover Endocrinology and Metabolism, 2, 7. https://doi.org/10.1007/s44417-026-00021-8
Impact of yogurt and rolled oats consumption on the gut microbiome: a randomized crossover study displaying individual responses and general resilience
Rolled oats are a source of prebiotics, particularly β-glucans, which are known to support cardiovascular health; however, their exact mechanisms of action and interactions with the gut microorganisms require further investigation. This 16-week, randomized, open-label, two-period crossover trial investigated the effects of daily yogurt and rolled oat consumption on gut microbial composition. A total of 119 healthy participants were included and consumed either 250 g/day of yogurt alone or 250 g of yogurt with 50 g of rolled oats, in a crossover design with a four-week intervention period and a four-week washout period. Blood and stool samples were collected from participants at baseline and post intervention to assess metabolomic and metabolic outcomes, respectively. Taxonomic analysis of stool samples showed that yogurt-derived bacteria including Streptococcus thermophilus and Lactobacillus delbrueckii were enriched after consumption of 250 g of yogurt daily, but the addition of 50 g of rolled oats with yogurt had no effect on the abundance of the two yogurt bacteria in the stool samples. Overall, 4-week consumption of yogurt or yogurt in combination with rolled oats did not lead to significant changes in the gut microbiome of healthy individuals. Future research is needed to confirm the prebiotic benefits of rolled oats in populations with dysbiotic gut microbiomes.
Key Takeaways:
- This study evaluated the effects of yogurt and rolled oat consumption on gut microbiota in healthy individuals.
- Daily yogurt consumption increased specific bacteria, including Streptococcus thermophilus and Lactobacillus delbrueckii; however, these effects were transient, and the addition of rolled oats did not influence this outcome.
- Future research should focus on populations with gut microbiome dysbiosis to better evaluate shifts in microbiota composition.
Access the study: https://www.sciencedirect.com/science/article/pii/S002231662600057X?via%3Dihub
Reference: Thriene, K., Stanislas, V., Huang, K. D., Strowig, T., & Michels, K. B. (2026). Impact of Yogurt and Rolled Oats Consumption on the Gut Microbiome: A Randomized Crossover Study Displaying Individual Responses and General Resilience. The Journal of nutrition, 156(4), 101408. Advance online publication. https://doi.org/10.1016/j.tjnut.2026.101408
Effects of phenolic‐rich extra virgin olive oil and prebiotics on sarcopenia in older adults: FOOP‐Sarc project
Sarcopenia is characterized by a decline in skeletal muscle mass and function, leading to an increased risk of fractures, falls, mortality, and a loss of independence. This 24‐week randomised, double‐blind, placebo‐controlled, parallel clinical trial assessed the effectiveness of a phenolic‐rich extra virgin olive oil (EVOO), alone or combined with fructooligosaccharides (FOS) and inulin, in improving skeletal muscle mass and function in older adults with at least one altered sarcopenia parameter. A total of 38 participants (aged 60-80 years) with probable sarcopenia were randomized into one of three groups: 1) control group (refined olive oil and maltodextrin); 2) EVOO group (EVOO and maltodextrin); or 3) EVOO + PREB group (EVOO and the two prebiotics). EVOO was used at a dose of 30 mL/day as a dressing and the prebiotic blend and maltodextrin were used at a dose of 7.5 g/day diluted in a glass of water. The primary outcome of the study was changes in muscle mass. Results showed a significant increase in skeletal muscle mass and appendicular skeletal muscle mass in the EVOO + PREB group and EVOO group at the 12-week follow-up. Improvements were also observed in ultrasound parameters of the quadriceps and rectus femoris by the end of the intervention. These findings support exploring larger studies to confirm the synergistic effects of EVOO rich in phenolic compounds combined with prebiotics such as FOS and inulin in populations with sarcopenia.
Key Takeaways:
- Sarcopenia affects skeletal muscle mass and function, increasing the risk of fractures, falls, and mortality.
- This study assessed the effectiveness of a phenolic‐rich EVOO, alone or combined with prebiotics, in improving skeletal muscle mass and function in older adults with at least one sarcopenia parameter altered.
- Consumption of EVOO with FOS and inulin led to improvements in skeletal muscle mass after a 12-week follow-up.
Access the study: https://onlinelibrary.wiley.com/doi/full/10.1002/jcsm.70247
Reference: Besora-Moreno, M., Jiménez-Ten Hoevel, C., Queral, J., Bernal, G., Pérez-Merino, L., Puzo, J., Conangla-Ferrin, L., Constance Sleebos, L., van Helden, W., Llauradó, E., Valls, R. M., Solà, R., & Pedret, A. (2026). Effects of Phenolic-Rich Extra Virgin Olive Oil and Prebiotics on Sarcopenia in Older Adults: FOOP-Sarc Project. Journal of cachexia, sarcopenia and muscle, 17(2), e70247. https://doi.org/10.1002/jcsm.70247
Short-chain oat fiber improves gastrointestinal tolerance and regulates glucose metabolism: a two-week open-label study in healthy adults
Humans lack the digestive enzymes to cleave the β1-4 and β1-3 glucose linear bonds of β-glucans, such as those found in oat fiber; therefore, these compounds are metabolized by the gut microbiota. This 14-day prospective, open-label, three-arm clinical study evaluated the effects of daily oral intake of different doses of short-chain oat fiber in healthy adults. A total of 67 participants (aged 18 to 70 years) were randomized to received 5 g, 10 g, or 20 g of short-chain oat fiber daily, followed by an at-home rice challenge to evaluate postprandial glucose responses. The outcomes of the study were gastrointestinal tolerability of the different doses of short-chain oat fiber as measured by the Gastrointestinal Symptom Rating Scale (GSRS), postprandial glucose uptake, and glucose uptake dynamics. Other outcomes included appetite, anxiety, mood, irritability, anhedonia, concentration, and sleep. Results showed that, despite showing no or low gastrointestinal symptoms at baseline, the 5 g/day and 10 g/day dose groups reported significant improvements in gastrointestinal symptoms, including abdominal pain and constipation. The intake of short-chain oat fiber also showed dose- and time-dependent reductions in postprandial peak glucose following rice consumption, with the greatest effect observed at 20 g/day. Furthermore, by the end of the study, reductions in peak glucose during the rice challenge were observed in 54%, 69%, and 83% of participants in the 5, 10, and 20 g/day groups, respectively, compared to baseline. An exploratory analysis showed that the consumption of short-chain oat fiber may improve mental health outcomes such as anxiety, worry, irritability, anhedonia, and life difficulty in those with elevated baseline symptoms. Overall, this study suggests that short-chain oat fiber improves glycemic and gastrointestinal outcomes and may also confer benefits on mental health in healthy adults.
Key Takeaways:
- β-glucans in oat fiber are indigestible by humans and are instead metabolized by the gut microbiota.
- Participants experienced improvements in postprandial peak glucose at increasing doses of short-chain oat fiber.
- Short-chain oat fiber shows potential benefits for glycemic control, gastrointestinal health, and mental well-being in healthy adults, though further research is needed.
Access the study: https://doi.org/10.64898/2026.01.21.26343795
Reference: Marcobal, A. M., Ng, K. M., Drexler, R. A., McConnell, B. R., & Amicucci, M. J. (2026). Short-Chain Oat Fiber Improves Gastrointestinal Tolerance and Regulates Glucose Metabolism: A Two-Week Open-Label Study in Healthy Adults. medRxiv, 2026-01.